Pfizer gene therapy reduces bleeding rates in haemophilia A in late-stage study
Pfizer the company reported that a gene therapy for haemophilia A significantly reduced the number of annual bleeding episodes in patients with the rare disease in a late-stage study and showed better outcomes than current standard treatment.
BELIEBTE BEITRÄGE
IEA warns ‘electricity era’ will come after fossil fuels peak
Oktober 17, 2024
Easter Island fights global plastic waste vortex
Oktober 17, 2024
Egypt opens more galleries at its antiquities museum
Oktober 17, 2024
LIVEÜBERTRAGUNG